ArticleInternational journal of biological sciences2025

The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy.

Tingting Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.